Creative Biostructure Announces the Release of a Bunch of COVID-19 Related VLP Products

February 25 18:06 2021
In the current continuous outbreak of SARS-CoV-2 / COVID-19, Creative Biostructure announced the release of a bunch of COVID-19 related VLP products for research use.

New York, USA – February 25, 2021 – In the current continuous outbreak of SARS-CoV-2 / COVID-19, Creative Biostructure, as an advanced supplier, announced the release of a bunch of COVID-19 related VLP products for research use.

SARS-CoV-2 has structural features similar to those of other coronaviruses. Coronavirus particles have four major structural proteins, namely membrane (M) proteins, nucleocapsid (N) proteins, spinous process (S) proteins and envelope (E) proteins, as well as several accessory proteins. Non-infectious virus-like particles (VLPs) displaying key viral proteins can be used to study the structural properties of native viruses. In addition, VLPs do not contain any viral genetic material and have the potential to trigger a robust immune response, providing a safer option for vaccine development.

Currently, Creative Biostructure has successfully created SARS-CoV-2 VLPs composed of M, N, S, and E in mammalian cells. COVID-19 related VLP products at Creative Biostructure include: SARS-CoV-2 VLP (M; N; S; E Proteins), COVID-19 VLP (S; GFP Protein), COVID-19 VLP (S; Luciferase), Mouse hepatitis virus A59 VLP (S; E; M; N Proteins), Mouse hepatitis virus A59 VLP (S Proteins), Mouse hepatitis virus VLP (M; N Proteins), SARS-CoV VLP (S; E; M Proteins), SARS-CoV VLP (M; N; S; E Proteins), SARS-CoV VLP (E; N; M Proteins), SARS-CoV VLP (Membrane Protein), Chimeric SARS-CoV & HIV-1 VLP (N; NC Proteins), and Chimeric SARS-CoV & MHV VLP (S(SCoV); M(MHV); N(MHV); E(MHV) Proteins).

Among them, products like COVID-19 VLP (S; GFP Protein), COVID-19 VLP (S; Luciferase), and SARS-CoV-2 VLP (M; N; S; E Proteins) are off-the-shelf and are ready for immediate worldwide delivery.

“We offer highly purified COVID-19 related VLP products as antigens for research use only, mostly using a mammalian expression system. We have rich experience in the production of VLPs and can provide custom VLP synthesis services according to your experimental goals,” commented Joanna, the chief marketing staff at Creative Biostructure.

“We have also established a dedicated coronavirus service platform to assist with basic research on coronavirus bioinformatics analysis, viral particle identification and characterization, coronavirus-related protein interaction analysis, and protein structural analysis,” added Joanna.

If you want to get detailed information about the COVID-19 related VLP products offered by Creative Biostructure, please visit https://www.creative-biostructure.com/COVID-19-Related-VLP-Products-674.htm.

About Creative Biostructure

Creative Biostructure is specialized in providing contract services to both academia and biotech/pharmaceutical industries in the field of structural biology. The company offers insightful strategies and cost-effective services on structure determination of macromolecules using X-ray Crystallography, EM, NMR, etc.

Media Contact
Company Name: Creative Biostructure
Contact Person: Jerry
Email: Send Email
Phone: 1-516-855-7709
Country: United States
Website: https://www.creative-biostructure.com

  Categories: